Pharmacology and clinical evaluation of trametinib,a reversible inhibitor of MEK1/2
ZHENG Yu-jing
FENG Yu-fei
Keywords：trametinibmelanomareversible inhibitor of mitogen-activated extracellular signal-regulated kinase 1/2 (MEK1/2)pharmacologyclinical evaluation
Publication Date：2014-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)